faculty photo

Doris A. Stoffers

Associate Professor of Medicine
Department: Medicine

Contact information
726 Clinical Research Building (office)
725/720 Clinical Research Building (lab)
415 Curie Boulevard
Philadelphia, PA 19104-6145
Office: 215 573-5413
Fax: 215 898-5408
Education:
B.A. (Chemistry)
Johns Hopkins University , 1984.
M.D.
Johns Hopkins University, School of Medicine, 1991.
Ph.D. (Neuroscience)
Johns Hopkins University, School of Medicine, 1991.
Permanent link
 

Description of Research Expertise

Research Interests
- transcription factors and signal transduction
- embryonic development and adult regeneration of the endocrine pancreas
- relationship of defects in these pathways to the pathophysiology of diabetes mellitus, a disease caused by a deficiency in the production or action of insulin

Key words: Diabetes, insulin, beta cell, pancreas development, transcriptional regulation, signal transduction.

Description of Research
Research in our laboratory focuses on the embryonic development and adult regeneration of the endocrine pancreas, and the relationship of defects in these pathways to the pathophysiology of diabetes mellitus, a disease caused by a deficiency in the production or action of insulin. The beta cells of the endocrine pancreas are the only source of insulin production in the body- therefore the regulation of beta cell mass is pivotal to the development of diabetes and successful therapies aimed at correcting diabetes must impact beta cell growth and/or function. Further support for this focus derives from genetic studies linking monogenic forms of human diabetes to mutations in transcription factors that regulate the development of beta cell mass. A model example is the homeobox transcription factor, IPF-1/PDX-1, that plays critical roles in embryonic pancreas development and in differentiated islet beta cell function in the adult endocrine pancreas. Using cutting edge molecular methods, yeast two hybrid libraries, transgenic and knock-out mice, cDNA microarray, chromatin immunoprecipitation, human genetics, and genomic and proteomic approaches, our current projects include:

1. Characterization of a novel PDX C-terminus Interacting Factor, PCIF1, identified in a yeast two-hybrid screen. PCIF1 is a novel nuclear factor that recruits Pdx1 into a cullin3 based E3 ubiquitin ligase for polyubiquitination and proteasomal degradation. Biochemical, molecular, in vivo and human genetics approaches are being applied to elucidate the role of this novel regulatory molecule.
2. Examining the molecular mechanisms by which the incretin hormone GLP-1 stimulates expansion of beta cell mass, with a particular emphasis on signal transduction and the identification of molecular mechanisms whereby GLP-1 promotes beta cell regeneration and regulates PDX expression.
3. Elucidating molecular mechanisms underlying islet compensation for diet-induced insulin resistance.
4. Identifing targets of Pdx1, Pbx and Meis homeodomain factors in the pancreatic ß cell.

Rotation Projects for 2008-2009
Lab rotation projects are available in all of the major areas described above. Please arrange for an appointment to discuss.

Lab personnel:
Doris A. Stoffers, MD, PhD, Principal Investigator
Jiangying Liu, PhD Postdoctoral Fellow
Ada Po Man Suen, PhD Postdoctoral Fellow
Scott Soleimanpour, MD, Postdoctoral Fellow
You Wang, Postdoctoral Fellow
Jennifer Oliver-Krasinski, Graduate Student
Mira Sachdeva, Graduate Student
Katy Claiborn, Graduate Student
Cynthia Khoo, Graduate Student
David Groff, Research Specialist
Juxiang Yang, PhD, Research Specialist

Selected Publications

Sachdeva MM and Stoffers DA: Meeting the demand for insulin: molecular mechanisms of postnatal beta cell mass expansion. Molecular Endocrinology 23(6): 747-758, Jun 2009 Notes: PMID: 19196831.

Habbe N, Shi G, Meguid RA, Fredrich V, Esni F, Chen H, Feldmann G, Stoffers DA, Konieczny SF, Leach SD, Miatra A: Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proceedings of the National Academy of Sciences (PNAS) 105(48): 8913-8, Dec 2008 Notes: PMID: 19028870.

De León DD, Li C, Delson MI, Matschinsky FM, Stanley CA, Stoffers DA: Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion. Journal of Biological Chemistry 283(38): 25786-25793, Sep 2008.

Oliver-Krasinski JM, Stoffers, DA: On the origin of the ß cell. Genes and Development 22(15): 1998-2021, Aug 2008.

Park JH, Stoffers DA, Nicholls RD, Simmons RA: Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1 The Journal of Clinical Investigation 118(6): 2316-2324, Jun 2008 Notes: PMID: 18464933

Desai BM., Oliver-Krasinski J., DeLeon DD., Farzad C., Hong N., Leach SD., Stoffers DA.: Pre-existing acinar cells contribute to acinar cell but not ß cell regeneration. Journal of Clinical Investigation 117: 971-977, April 2007.

Lee CS, De Leon DD, Kaestner KH and Stoffers DA: Regeneration of pancreatic islets after partial pancreatectomy does not involve the reactivation of neurogenin3. Diabetes 55(2): 269-72, Feb 2006.

Liu A, Desai BM and Stoffers DA: Identification of PCIF1, a novel nuclear factor that inhibits PDX-1 (MODY4) transactivation. Molecular Cellular Biology 24: 4372-4383, 2004.

Stoffers DA*, Desai BM, DeLeon DD, and Simmons RA: Neonatal Exendin-4 Prevents the Development of Diabetes Mellitus in the Intrauterine Growth Retarded Rat. Diabetes 52: 365-371 *corresponding author, 2003.

back to top
Last updated: 11/04/2009
The Trustees of the University of Pennsylvania
 
Untitled Document